Menu

Home / For Visitors / Exhibitor Product / Preclinical Services: Early-Drug Discovery

Preclinical Services: Early-Drug Discovery

Model: Organoids

Category: *CRO

Exhibitor: BIOMORGAN LIMITED

Booth No: N/A

Characteristic

Comprehensive in vitro platforms supporting early-stage drug development, toxicology profiling, and disease modeling using high-quality human organoids.

Early-Drug Discovery
• Antiviral Activity
• Anti-inflammatory Effects
• Anti-fibrotic Properties

Toxicology
• 7-day Dose-range Finding
• 14-day Acute Toxicity
• 28-day Chronic Toxicity

Disease Modeling
• Viral Infections: COVID-19, Influenza, HRV, RSV
• Respiratory Diseases: Asthma, COPD, etc.

Customization
• Customized Assays and Model Development

Other Products

Products you may be interested in

Highest Rated Products

TOP